Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adrenergic Agonists: Indirect-Acting Agents

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...

Adrenergic Agonists: Mixed-Action Agents

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

CNS Stimulants: Psychedelic Agents

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...

Amnesia

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ethical and legal challenges of integrating artificial intelligence into paediatric surgery.

Annals of the Royal College of Surgeons of England·2026

Same author

Knowledge, awareness and practices regarding human papillomavirus vaccine amongst secondary school girls and mothers in North India.

European journal of obstetrics, gynecology, and reproductive biology·2026

Same author

Maternal risk factors and closure techniques in gastroschisis: a 16-year retrospective review from a UK tertiary centre.

Pediatric surgery international·2025

Same author

From expectations to experiences: a systematic review of patient and public perspectives on robotic surgery.

Journal of robotic surgery·2025

Same author

Talk smart, treat better.

British dental journal·2025

Same author

Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial.

European journal of cancer (Oxford, England : 1990)·2025

Search research articles

Related Experiment Video

Updated: Apr 25, 2026

Neuropharmacological Manipulation of Restrained and Free-flying Honey Bees, Apis mellifera

Neuropharmacological Manipulation of Restrained and Free-flying Honey Bees, Apis mellifera

Published on: November 26, 2016

Phenylephrine and ECS-induced retrograde amnesia.

A Anand¹, C Andrade, S Sudha

¹Department of Pharmacology, St. John's Medical College, Bangalore, India.

The Journal of ECT

|August 31, 2001

Summary

This summary is machine-generated.

Phenylephrine administration before electroconvulsive shocks (ECS) did not prevent amnesia but improved memory recall. This suggests phenylephrine may enhance cognitive functions through adrenergic mechanisms.

More Related Videos

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Related Experiment Videos

Last Updated: Apr 25, 2026

Neuropharmacological Manipulation of Restrained and Free-flying Honey Bees, Apis mellifera

Neuropharmacological Manipulation of Restrained and Free-flying Honey Bees, Apis mellifera

Published on: November 26, 2016

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Area of Science:

Neuroscience
Pharmacology

Background:

Electroconvulsive shocks (ECS) can induce retrograde amnesia, potentially linked to seizure-related physiological changes.
Phenylephrine, a nonselective alpha-receptor agonist, affects blood pressure and adrenergic signaling.

Purpose of the Study:

To investigate if phenylephrine administration before ECS can attenuate ECS-induced retrograde amnesia.
To explore the potential cognitive-enhancing effects of phenylephrine.

Main Methods:

Adult male Wistar rats were administered phenylephrine or saline before daily true or sham ECS.
Memory retention was assessed using a passive avoidance task 24 hours after ECS treatment.

Main Results:

Phenylephrine increased seizure duration in rats receiving ECS.
Phenylephrine administration enhanced memory recall in both true and sham ECS groups.
These findings suggest a non-specific cognitive-enhancing effect of phenylephrine.

Conclusions:

Phenylephrine did not attenuate ECS-induced amnesia but demonstrated a general improvement in cognitive function.
Adrenergic mechanisms may underlie phenylephrine's memory-enhancing effects.
The study challenges the hypothesis that ECS-induced cognitive impairment is solely due to seizure-related hypertension.